NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,820,000 | +9.5% | 34,189 | -3.8% | 0.18% | +18.1% |
| Q1 2016 | $2,575,000 | +28.1% | 35,556 | +52.2% | 0.16% | +31.4% |
| Q4 2015 | $2,010,000 | -10.8% | 23,362 | -4.7% | 0.12% | +6.3% |
| Q3 2015 | $2,253,000 | +0.4% | 24,513 | +7.4% | 0.11% | +14.4% |
| Q2 2015 | $2,243,000 | +7.9% | 22,816 | +8.5% | 0.10% | +15.5% |
| Q1 2015 | $2,079,000 | -59.2% | 21,030 | -61.7% | 0.08% | -59.4% |
| Q4 2014 | $5,093,000 | +3.1% | 54,966 | +4.8% | 0.21% | +13.7% |
| Q3 2014 | $4,938,000 | -66.8% | 52,461 | -68.1% | 0.18% | -63.9% |
| Q2 2014 | $14,877,000 | +1.3% | 164,331 | -4.8% | 0.50% | +37.3% |
| Q1 2014 | $14,682,000 | -24.8% | 172,692 | -28.9% | 0.37% | -24.2% |
| Q4 2013 | $19,518,000 | +0.5% | 242,826 | -4.1% | 0.48% | -6.6% |
| Q3 2013 | $19,428,000 | +41.4% | 253,269 | +30.3% | 0.52% | +25.7% |
| Q2 2013 | $13,740,000 | – | 194,315 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |